Flu Vaccines

Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development

Published in TB and Outbreaks Week, February 17th, 2009

The Center for Molecular Biology (CMB) has received an $8.7 million grant from the Bill & Melinda Gates Foundation to support continued development of an avian influenza vaccine that uses transient plant-based technology. CMB will develop vaccines against highly pathogenic avian influenza viruses of H5N1 subtype, and work to advance promising candidates into clinical trials.

Dr. Vidadi Yusibov, CMB's Executive Director said, "CMB's vaccine technology has the potential to revolutionize how vaccines are manufactured, allowing for a more rapid and affordable response to pandemic flu threats."

"It is essential that new vaccines reach the people who need...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2009-02-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry